BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1461951)

  • 1. Age and the dexamethasone suppression test: results from a broad unselected patient population.
    Keitner GI; Ryan CE; Kohn R; Miller IW; Norman WH; Brown WA
    Psychiatry Res; 1992 Oct; 44(1):9-20. PubMed ID: 1461951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reported weight loss and dexamethasone nonsuppression in depressed patients. A negative study.
    Gwirtsman HE; Roy-Byrne P; Gitlin MJ; Halaris A; Ahles S
    J Affect Disord; 1985 Sep; 9(2):193-6. PubMed ID: 2932495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
    Arana GW; Wilens TE; Baldessarini RJ
    Psychoneuroendocrinology; 1985; 10(1):49-60. PubMed ID: 4001277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPA axis function and temperament in depression: a negative report.
    Roy A
    Biol Psychiatry; 1996 Mar; 39(5):364-6. PubMed ID: 8704068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents.
    Evans DL; Nemeroff CB; Haggerty JJ; Pedersen CA
    Psychoneuroendocrinology; 1987; 12(3):203-9. PubMed ID: 3615749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
    Holsboer F; von Bardeleben U; Wiedemann K; Müller OA; Stalla GK
    Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512
    [No Abstract]   [Full Text] [Related]  

  • 8. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic function and the cortisol response to dexamethasone in depression.
    Rubin AL; Price LH; Charney DS; Heninger GR
    Psychiatry Res; 1985 May; 15(1):5-15. PubMed ID: 2989963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients.
    Axelson DA; Doraiswamy PM; Boyko OB; Rodrigo Escalona P; McDonald WM; Ritchie JC; Patterson LJ; Ellinwood EH; Nemeroff CB; Krishnan KR
    Psychiatry Res; 1992 Oct; 44(1):63-70. PubMed ID: 1461948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
    Tajima-Pozo K; Montes-Montero A; Güemes I; González-Vives S; Díaz-Marsá M; Carrasco JL
    Endocrinol Nutr; 2013; 60(7):396-403. PubMed ID: 23623464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-adrenal axis activity and age in major depression.
    Nelson WH; Orr WW; Shane SR; Stevenson JM
    J Clin Psychiatry; 1984 Mar; 45(3):120-1. PubMed ID: 6698943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test in a general hospital psychiatric setting.
    Warneke LB
    Can J Psychiatry; 1985 Dec; 30(8):614-8. PubMed ID: 4084903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test and pituitary-adrenocortical function.
    Brown WA; Keitner G; Qualls CB; Haier R
    Arch Gen Psychiatry; 1985 Feb; 42(2):121-3. PubMed ID: 3977539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
    Bagdy G; Rihmer Z; Frecska E; Szádóczky E; Arató M
    Psychoneuroendocrinology; 1986; 11(1):117-20. PubMed ID: 3704065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmatic vasopressin neurophysin in depression: basic levels and relations with HPA axis.
    Laruelle M; Seghers A; Goffinet S; Bouchez S; Legros JJ
    Biol Psychiatry; 1990 Jun; 27(11):1249-63. PubMed ID: 2354230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania.
    Swann AC; Stokes PE; Casper R; Secunda SK; Bowden CL; Berman N; Katz MM; Robins E
    Acta Psychiatr Scand; 1992 Apr; 85(4):270-4. PubMed ID: 1595360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression test in psychiatric patients with psychoactive substance dependence.
    Olivera AA; Fero D; Scibilia J
    Am J Drug Alcohol Abuse; 1991 Sep; 17(3):295-305. PubMed ID: 1928023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.